• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

为什么结构和链长很重要:探讨多聚(ADP-核糖)结构异质性的生物学意义。

Why structure and chain length matter: on the biological significance underlying the structural heterogeneity of poly(ADP-ribose).

机构信息

Department of Biology, University of Konstanz, 78467 Konstanz, Germany.

出版信息

Nucleic Acids Res. 2021 Sep 7;49(15):8432-8448. doi: 10.1093/nar/gkab618.

DOI:10.1093/nar/gkab618
PMID:34302489
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8421145/
Abstract

Poly(ADP-ribosyl)ation (PARylation) is a multifaceted post-translational modification, carried out by poly(ADP-ribosyl)transferases (poly-ARTs, PARPs), which play essential roles in (patho-) physiology, as well as cancer therapy. Using NAD+ as a substrate, acceptors, such as proteins and nucleic acids, can be modified with either single ADP-ribose units or polymers, varying considerably in length and branching. Recently, the importance of PAR structural heterogeneity with regards to chain length and branching came into focus. Here, we provide a concise overview on the current knowledge of the biochemical and physiological significance of such differently structured PAR. There is increasing evidence revealing that PAR's structural diversity influences the binding characteristics of its readers, PAR catabolism, and the dynamics of biomolecular condensates. Thereby, it shapes various cellular processes, such as DNA damage response and cell cycle regulation. Contrary to the knowledge on the consequences of PAR's structural diversity, insight into its determinants is just emerging, pointing to specific roles of different PARP members and accessory factors. In the future, it will be interesting to study the interplay with other post-translational modifications, the contribution of natural PARP variants, and the regulatory role of accessory molecules. This has the exciting potential for new therapeutic approaches, with the targeted modulation and tuning of PARPs' enzymatic functions, rather than their complete inhibition, as a central premise.

摘要

聚(ADP-核糖)化(PARylation)是一种多方面的翻译后修饰,由聚(ADP-核糖)转移酶(poly-ARTs,PARPs)执行,它们在(病理)生理学以及癌症治疗中发挥着重要作用。PARPs 使用 NAD+ 作为底物,可将单个 ADP-核糖单位或聚合物修饰到蛋白质和核酸等受体上,其长度和分支变化很大。最近,PAR 结构异质性在链长和分支方面的重要性引起了关注。在这里,我们简要概述了这种不同结构 PAR 的生化和生理意义的最新知识。越来越多的证据表明,PAR 的结构多样性会影响其结合特性、PAR 代谢和生物分子凝聚物的动力学。从而影响各种细胞过程,如 DNA 损伤反应和细胞周期调控。与 PAR 结构多样性的后果知识相反,其决定因素的认识才刚刚开始,这指向了不同 PARP 成员和辅助因子的特定作用。未来,研究与其他翻译后修饰的相互作用、天然 PARP 变体的贡献以及辅助分子的调节作用将很有趣。这为新的治疗方法提供了令人兴奋的潜力,靶向调节和调整 PARPs 的酶功能,而不是完全抑制它们,是一个核心前提。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28ab/8421145/d2f053d7c9b5/gkab618fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28ab/8421145/e299907332a0/gkab618gra1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28ab/8421145/01ebdedea366/gkab618fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28ab/8421145/d2f053d7c9b5/gkab618fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28ab/8421145/e299907332a0/gkab618gra1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28ab/8421145/01ebdedea366/gkab618fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28ab/8421145/d2f053d7c9b5/gkab618fig2.jpg

相似文献

1
Why structure and chain length matter: on the biological significance underlying the structural heterogeneity of poly(ADP-ribose).为什么结构和链长很重要:探讨多聚(ADP-核糖)结构异质性的生物学意义。
Nucleic Acids Res. 2021 Sep 7;49(15):8432-8448. doi: 10.1093/nar/gkab618.
2
Poly-ADP ribosylation in DNA damage response and cancer therapy.聚腺苷二磷酸核糖基化在 DNA 损伤反应和癌症治疗中的作用。
Mutat Res Rev Mutat Res. 2019 Apr-Jun;780:82-91. doi: 10.1016/j.mrrev.2017.09.004. Epub 2017 Sep 20.
3
Poly(ADP-ribose): PARadigms and PARadoxes.多聚(ADP-核糖):PARadigms 和 PARadoxes。
Mol Aspects Med. 2013 Dec;34(6):1046-65. doi: 10.1016/j.mam.2012.12.010. Epub 2013 Jan 2.
4
Generating Protein-Linked and Protein-Free Mono-, Oligo-, and Poly(ADP-Ribose) In Vitro.体外生成蛋白质连接的和无蛋白质的单聚、寡聚和多聚(ADP-核糖)
Methods Mol Biol. 2018;1813:91-108. doi: 10.1007/978-1-4939-8588-3_7.
5
MARTs and MARylation in the Cytosol: Biological Functions, Mechanisms of Action, and Therapeutic Potential.细胞质中的 MARTs 和 MARylation:生物学功能、作用机制和治疗潜力。
Cells. 2021 Feb 3;10(2):313. doi: 10.3390/cells10020313.
6
The poly(ADP-ribose) polymerases (PARPs): new roles in intracellular transport.聚(ADP-核糖)聚合酶(PARPs):细胞内运输的新作用。
Cell Signal. 2012 Jan;24(1):1-8. doi: 10.1016/j.cellsig.2011.07.019. Epub 2011 Aug 5.
7
Nucleolar-nucleoplasmic shuttling of TARG1 and its control by DNA damage-induced poly-ADP-ribosylation and by nucleolar transcription.核仁-核质穿梭的 TARG1 和其控制的 DNA 损伤诱导的聚 ADP-核糖化和核仁转录。
Sci Rep. 2018 Apr 30;8(1):6748. doi: 10.1038/s41598-018-25137-w.
8
Mechanisms governing PARP expression, localization, and activity in cells.细胞中 PARP 表达、定位和活性的调控机制。
Crit Rev Biochem Mol Biol. 2020 Dec;55(6):541-554. doi: 10.1080/10409238.2020.1818686. Epub 2020 Sep 23.
9
Poly(ADP-ribosyl)ation by PARP1: reaction mechanism and regulatory proteins.聚(ADP-核糖)化由 PARP1 介导:反应机制和调节蛋白。
Nucleic Acids Res. 2019 May 7;47(8):3811-3827. doi: 10.1093/nar/gkz120.
10
Ex vivo supplementation with nicotinic acid enhances cellular poly(ADP-ribosyl)ation and improves cell viability in human peripheral blood mononuclear cells.体外补充烟酰胺酸可增强人外周血单核细胞的细胞多聚(ADP-核糖)化并提高细胞活力。
Biochem Pharmacol. 2010 Oct 1;80(7):1103-12. doi: 10.1016/j.bcp.2010.06.010. Epub 2010 Jun 25.

引用本文的文献

1
Overexpression of the WWE domain of RNF146 modulates poly-(ADP)-ribose dynamics at sites of DNA damage.RNF146的WWE结构域的过表达调节DNA损伤位点处的聚(ADP)核糖动力学。
DNA Repair (Amst). 2025 Jun;150:103845. doi: 10.1016/j.dnarep.2025.103845. Epub 2025 May 21.
2
dELTA-MS: A Mass Spectrometry-Based Proteomics Approach for Identifying ADP-Ribosylation Sites and Forms.Δ-MS:一种基于质谱的蛋白质组学方法,用于鉴定ADP-核糖基化位点和形式。
J Proteome Res. 2025 Apr 4;24(4):1791-1803. doi: 10.1021/acs.jproteome.4c00890. Epub 2025 Mar 13.
3
Poly ADP-ribose signaling is dysregulated in Huntington disease.

本文引用的文献

1
Unrestrained poly-ADP-ribosylation provides insights into chromatin regulation and human disease.无约束的多聚 ADP-核糖基化提供了对染色质调控和人类疾病的深入了解。
Mol Cell. 2021 Jun 17;81(12):2640-2655.e8. doi: 10.1016/j.molcel.2021.04.028. Epub 2021 May 20.
2
Uncovering the Invisible: Mono-ADP-ribosylation Moved into the Spotlight.揭示隐匿的真相:单 ADP-核糖基化作用备受瞩目。
Cells. 2021 Mar 19;10(3):680. doi: 10.3390/cells10030680.
3
An Overview of PARP Inhibitors for the Treatment of Breast Cancer.PARP 抑制剂在乳腺癌治疗中的概述。
多聚 ADP - 核糖信号传导在亨廷顿病中失调。
Proc Natl Acad Sci U S A. 2024 Oct;121(40):e2318098121. doi: 10.1073/pnas.2318098121. Epub 2024 Sep 27.
4
Divalent and multivalent cations control liquid-like assembly of poly(ADP-ribosyl)ated PARP1 into multimolecular associates in vitro.二价和多价阳离子控制聚(ADP-核糖基)化 PARP1 在体外形成多分子聚集体的液态样组装。
Commun Biol. 2024 Sep 15;7(1):1148. doi: 10.1038/s42003-024-06811-4.
5
Cation-induced intramolecular coil-to-globule transition in poly(ADP-ribose).聚(ADP-核糖)中的离子诱导分子内卷曲到球的转变。
Nat Commun. 2024 Sep 10;15(1):7901. doi: 10.1038/s41467-024-51972-9.
6
Poly-ADP-ribosylation dynamics, signaling, and analysis.多聚 ADP-核糖基化动力学、信号转导与分析。
Environ Mol Mutagen. 2024 Nov;65(9):315-337. doi: 10.1002/em.22623. Epub 2024 Sep 2.
7
Monitoring nucleolar-nucleoplasmic protein shuttling in living cells by high-content microscopy and automated image analysis.通过高内涵显微镜和自动化图像分析监测活细胞中的核仁-核质蛋白穿梭。
Nucleic Acids Res. 2024 Aug 27;52(15):e72. doi: 10.1093/nar/gkae598.
8
PARticular MARks: Histone ADP-ribosylation and the DNA damage response.特殊标记:组蛋白 ADP-ribosylation 和 DNA 损伤反应。
DNA Repair (Amst). 2024 Aug;140:103711. doi: 10.1016/j.dnarep.2024.103711. Epub 2024 Jun 22.
9
Exploring the role of parthanatos in CNS injury: Molecular insights and therapeutic approaches.探索细胞焦亡在中枢神经系统损伤中的作用:分子见解与治疗方法。
J Adv Res. 2025 Apr;70:271-286. doi: 10.1016/j.jare.2024.04.031. Epub 2024 May 3.
10
Specific and shared biological functions of PARP2 - is PARP2 really a lil' brother of PARP1?PARP2的特异性和共享生物学功能——PARP2真的是PARP1的“小弟”吗?
Expert Rev Mol Med. 2024 May 3;26:e13. doi: 10.1017/erm.2024.14.
Target Oncol. 2021 May;16(3):255-282. doi: 10.1007/s11523-021-00796-4. Epub 2021 Mar 12.
4
ADP-ribosylation of RNA and DNA: from in vitro characterization to in vivo function.RNA和DNA的ADP核糖基化:从体外特性到体内功能
Nucleic Acids Res. 2021 Apr 19;49(7):3634-3650. doi: 10.1093/nar/gkab136.
5
HPF1 and nucleosomes mediate a dramatic switch in activity of PARP1 from polymerase to hydrolase.HPF1 和核小体介导 PARP1 从聚合酶到水解酶活性的剧烈转变。
Elife. 2021 Mar 8;10:e65773. doi: 10.7554/eLife.65773.
6
Rapid Detection and Signaling of DNA Damage by PARP-1.PARP-1 对 DNA 损伤的快速检测和信号转导。
Trends Biochem Sci. 2021 Sep;46(9):744-757. doi: 10.1016/j.tibs.2021.01.014. Epub 2021 Mar 3.
7
Cells recognize osmotic stress through liquid-liquid phase separation lubricated with poly(ADP-ribose).细胞通过液-液相分离识别渗透应激,这种分离由多聚(ADP-核糖)润滑。
Nat Commun. 2021 Mar 1;12(1):1353. doi: 10.1038/s41467-021-21614-5.
8
Identifying Poly(ADP-ribose)-Binding Proteins with Photoaffinity-Based Proteomics.用基于光亲和性的蛋白质组学鉴定聚(ADP-核糖)结合蛋白。
J Am Chem Soc. 2021 Mar 3;143(8):3037-3042. doi: 10.1021/jacs.0c12246. Epub 2021 Feb 17.
9
HPF1 remodels the active site of PARP1 to enable the serine ADP-ribosylation of histones.HPF1 重塑 PARP1 的活性位点,从而使组蛋白丝氨酸发生 ADP-核糖基化。
Nat Commun. 2021 Feb 15;12(1):1028. doi: 10.1038/s41467-021-21302-4.
10
PARP Inhibitors in Small-Cell Lung Cancer: Rational Combinations to Improve Responses.PARP抑制剂在小细胞肺癌中的应用:改善疗效的合理联合方案
Cancers (Basel). 2021 Feb 10;13(4):727. doi: 10.3390/cancers13040727.